Skip to content

Clinical trials

Terminated Pulmonary Arterial Hypertension trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Terminated Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20104
20111
20131
20141
20151
20162
20192
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion4
Aerovate Therapeutics2
Idorsia Pharmaceuticals Ltd.2
Pfizer2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Bellerophon Pulse Technologies1
Centre Hospitalier Universitaire de Nice1
GlaxoSmithKline1
Gossamer Bio USA, Inc.1
Keros Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension19
Hypertension, Pulmonary4
Aortic Valve Stenosis1
Connective Tissue Diseases1
Eisenmenger Complex1
Familial Primary Pulmonary Hypertension1
Hypertension1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.